Generic Injectables Global Market Report 2022: Supportive Government Initiatives Drive Sector Growth -

DUBLIN--()--The "Generic Injectables Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to's offering.

The global generic injectable market is expected to grow at a CAGR of around 7.8% during 2023-2030. This report on global generic injectable market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape.

The report presents a clear picture of the global generic injectable market by segmenting the market based on therapeutic area, containers, distribution channel, and region. Also, detailed profiles of companies operating in the generic injectable market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

  • Government Taking Initiatives to Support Manufacture in Various Countries
  • Aging Population and Rising Prevalence of Chronic Diseases
  • Cheaper and Shorter R&D

Market Challenges

  • Contamination Concerns for Injectable Manufactured in Factories in Some Countries

Historical & Forecast Period

  • Base Year: 2022
  • Historical Period: 2018-2022
  • Forecast Period: 2023-2030

Market by Therapeutic Area

  • Oncology
  • Anaesthesia
  • Anti-infective
  • Parenteral Nutrition
  • Cardiovascular Diseases

Market by Containers

  • Vials
  • Ampoules
  • Premix
  • Prefilled Syringes

Market by Distribution Channel

  • Hospitals
  • Retail Pharmacy

Market by Region

  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Rest of Asia Pacific
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • Turkey
  • Iran
  • Rest of Middle East & Africa



Key Topics Covered:

1. Preface

2. Key Insights

3. Global Generic Injectable Market

4. Global Generic Injectable Market Analysis

5. Global Generic Injectable Market by Therapeutic Area

6. Global Generic Injectable Market by Containers

7. Global Generic Injectable Market by Distribution Channel

8. Global Generic Injectable Market by Region

9. SWOT Analysis

10. Porter's Five Forces

11. Market Value Chain Analysis

12. Competitive Landscape

Companies Mentioned

  • Hospira (Pfizer)
  • Fresenius Kabi
  • Hikma Pharma PLC
  • Sandoz (Novartis)
  • Sagent Inc.
  • Sanofi
  • Baxter
  • Dr. Reddy Laboratories
  • Akorn Inc.
  • Fresenius SE & Co. KGaA
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd
  • Lupin Ltd
  • Aurobindo Pharma
  • Biocon

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900